Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancers. - Wikidata - wikimedia - TriplyDB

Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancers.

Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancers.

http://www.wikidata.org/entity/Q35022384

about

Polymorphisms and haplotypes in the caspase-3, caspase-7, and caspase-8 genes and risk for endometrial cancer: a population-based, case-control study in a Chinese population Molecular models for the tissue specificity of DNA mismatch repair-deficient carcinogenesis Clinical Challenges Associated with Universal Screening for Lynch Syndrome-Associated Endometrial Cancer.Assessing the prognostic role of ATR mutation in endometrioid endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study Genetic testing strategies in newly diagnosed endometrial cancer patients aimed at reducing morbidity or mortality from lynch syndrome in the index case or her relatives Does risk of endometrial cancer for women without a germline mutation in a DNA mismatch repair gene depend on family history of endometrial cancer or colorectal cancer?Endometrial cancer and a family history of cancer.Current and emerging trends in Lynch syndrome identification in women with endometrial cancer.Role of the clinical pathology laboratory in the evaluation of endometrial carcinomas for Lynch syndrome Penetrance and expressivity of MSH6 germline mutations in seven kindreds not ascertained by family history.MSH6 and PMS2 mutation positive Australian Lynch syndrome families: novel mutations, cancer risk and age of diagnosis of colorectal cancer.The emerging genomic landscape of endometrial cancer.Spreading of Alu methylation to the promoter of the MLH1 gene in gastrointestinal cancer.Absence of MGMT promoter methylation in endometrial cancer Sequencing of candidate chromosome instability genes in endometrial cancers reveals somatic mutations in ESCO1, CHTF18, and MRE11A Polymerase ɛ (POLE) mutations in endometrial cancer: clinical outcomes and implications for Lynch syndrome testing.Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for population-level germline mismatch repair gene mutation testing.Diagnosing Lynch syndrome: is the answer in the mouth?The hMLH1 -93G>A Polymorphism and Risk of Ovarian Cancer in the Chinese Population.Clinical and Molecular Characterization of Brazilian Patients Suspected to Have Lynch Syndrome.Characterization of two Ashkenazi Jewish founder mutations in MSH6 gene causing Lynch syndrome Do hereditary syndrome-related gynecologic cancers have any specific features?ColoSeq provides comprehensive lynch and polyposis syndrome mutational analysis using massively parallel sequencing.The genomics and genetics of endometrial cancer.Accuracy of MSI testing in predicting germline mutations of MSH2 and MLH1: a case study in Bayesian meta-analysis of diagnostic tests without a gold standard.Risks of colorectal and other cancers after endometrial cancer for women with Lynch syndrome Relationship of lower uterine segment cancer with Lynch syndrome: a novel case with an hMLH1 germline mutation Germline MSH6 mutations are more prevalent in endometrial cancer patient cohorts than hereditary non polyposis colorectal cancer cohorts Lynch syndrome related endometrial cancer: clinical significance beyond the endometrium Differential roles of telomere attrition in type I and II endometrial carcinogenesis.Application of Immunohistochemistry and Molecular Diagnostics to Clinically Relevant Problems in Endometrial Cancer Bojana Djordjevic, Shannon Westin, Russell R. Broaddus Testing women with endometrial cancer to detect Lynch syndrome.Anthropometric measures and the risk of endometrial cancer, overall and by tumor microsatellite status and histological subtype.Carcinoma of the lower uterine segment: a newly described association with Lynch syndrome.Genetic polymorphisms and endometrial cancer risk.Molecular pathogenesis of endometrial and ovarian cancer.Epitope-positive truncating MLH1 mutation and loss of PMS2: implications for IHC-directed genetic testing for Lynch syndrome.Meta-analysis of MSH6 gene mutation frequency in colorectal and endometrial cancers.Use of mutation profiles to refine the classification of endometrial carcinomas.

P2860

Q24651401-4B2DDE98-137C-4558-8A37-AC0CB50E3485 Q25257401-79C5411A-F514-41BB-A1AA-8688477213D9 Q30275239-4423F5A8-39A9-45FA-982E-CF7116E4C4A7 Q30356815-E5F0BB83-D102-4FC1-B178-D40793BE5486 Q30361978-C05DEF9A-1EFF-48F1-9763-1B4A05F86FF9 Q31139897-007D82C9-249F-477C-9101-91A65844F5F4 Q33593851-39133B14-16C2-4A22-8141-2DCECE187F20 Q33737568-307AE7BB-5164-40DC-9C12-F666B47B9996 Q33738168-E533B96D-6496-4934-A5DC-D4E69D8EC0C3 Q33817058-1A6CDF00-F067-41E3-9099-47DA90BA414C Q33910331-A61B50E8-E5C0-4C45-89A2-853896FED9DC Q33933576-7DEC6956-4ECF-4161-A5E8-C11B991B20E7 Q34026976-B569B118-7224-4261-95BE-C59B8C395DEE Q34055785-01B376C5-BF27-40B8-9FB1-82EEA470D55B Q34171450-76AD7112-5E9E-49BD-ACF1-CDB9E46CBDC5 Q34765551-4561579A-B9D1-481E-8C40-0EA972ADEEC1 Q35007615-1EE7CE1B-93CA-4197-92A1-62951DD71011 Q35063442-E85722B8-4DE4-4E97-A7DC-529CDEB55859 Q35596120-85E27828-2776-49BB-BA11-F90D268848D2 Q35746647-FB51794C-3EF1-4773-B447-A74E485E79C9 Q35799369-272A9502-603E-48CE-9A68-99162DAD32EE Q35971538-2F51A96E-4BB4-40CF-AEA3-C442FF7DDAE0 Q36059087-59ECFFD6-45D1-4827-89A7-9CBDB1C09ACD Q36081155-5F1F7292-DA43-41D4-84EF-F4B3321A222D Q36151896-D8C54353-F611-4301-B8BE-8DAC97AC17DA Q36507457-49D3ADA4-8FE9-4ED6-89F8-67FA3CB2B85D Q36621452-E61AC547-0CF2-4564-BED9-45B0E4651CC3 Q36642662-01901E73-8571-45F3-9619-2DF8C6B0F309 Q36677899-366BCB6E-241D-4ED9-A8DE-F4C4CAD69A64 Q36758454-6A15E8D2-48E7-4DEA-99BC-2156792FF129 Q36778280-1E8EE33D-17D7-4950-A2FB-FA572F9622D9 Q36841899-6AB24B2E-F059-4CDA-BDE2-F4C9F051AAA4 Q36920374-139B07CA-8CB6-4F9C-A961-23AF2D171BF1 Q37065996-E75ECCBA-2A84-44BC-9480-E5D25D923126 Q37103142-86F060DE-AB8E-4D3D-A787-AA0AE7494865 Q37202787-8358B74A-53B5-4F1C-B4A8-7160508894AA Q37293672-7A40FB57-10DB-4EDC-AF11-8AAD36A72D7F Q37407204-833D4832-DF16-488B-8CDF-B45BC98C1BDD Q37506265-89B37846-6412-4343-9641-D7803E4A3546 Q37612253-93CF680A-2713-4468-BC1D-C9BE8925BC3E

P2860

Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancers.

http://www.wikidata.org/entity/Q35022384

description

2003 nî lūn-bûn

@nan

2003 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Prevalence of defective DNA mi ...... series of endometrial cancers.

@ast

Prevalence of defective DNA mi ...... series of endometrial cancers.

@en

type

label

Prevalence of defective DNA mi ...... series of endometrial cancers.

@ast

Prevalence of defective DNA mi ...... series of endometrial cancers.

@en

prefLabel

Prevalence of defective DNA mi ...... series of endometrial cancers.

@ast

Prevalence of defective DNA mi ...... series of endometrial cancers.

@en

P1433

Q35022384-858D7CAB-9618-49FB-A06C-79CD26C3419F

P1476

Q35022384-7E3C1462-3632-41A1-A441-6B5F8341F4E8

P2093

Q35022384-05D32781-E93F-462D-801C-410515DB33F9

Q35022384-07E7D899-CF73-43D3-AC04-E3D4AE16C051

Q35022384-1E7BBBE8-AF6F-4D38-877F-4EF356442B2C

Q35022384-359DA22F-F76D-4261-8BD6-EED7DF8A6F21

Q35022384-84B2E85C-6E9B-47A0-84ED-E4DF1B0E3FE1

Q35022384-BEC30C18-80AC-4FE8-B9C5-D9F2628862A1

Q35022384-D062EF5C-23F6-4BE6-865E-673B69B8566E

Q35022384-D30FF2FD-D4D6-416C-A89C-7D91C9D84A64

Q35022384-D426FC75-406F-4ABB-8D1F-3AC59AA08E77

Q35022384-F1ACD941-3829-42BE-AB8B-68E2C4BD6908

P2860

Q35022384-13362F05-259A-4FB7-A566-A2BACE575A21

Q35022384-1A5CC11E-36E3-4CAD-B962-8DF3FFC86CF1

Q35022384-1F5C3739-F70C-4277-8A32-FD49E86D72DB

Q35022384-2F1050BD-601A-44A6-B94E-E25F792A1FDB

Q35022384-349C1EDA-D6A7-4DBC-BF02-22C7F8F28999

Q35022384-349DE1FD-B438-49F3-AEB6-EFCE6C45DDAB

Q35022384-4B556D8E-9530-4B9E-812E-FA57DB1369E0

Q35022384-5E191BA5-76D5-4F72-8784-ABFCA178919B

Q35022384-66CFC477-301B-4215-A200-B2F227C50A35

Q35022384-67753B89-1ACC-4073-8623-70346F160018

P304

Q35022384-9220B9E0-C614-4A3A-93B3-7A5B759C9182

P31

Q35022384-F889B1AA-222E-4A9E-B703-CCDB66907297

P3181

Q35022384-e9a59c10-4353-7b0d-971e-9e37b6e8afe6

P356

Q35022384-C1F2B217-8AAF-41B2-B0D8-E55F4E2E25D3

P407

Q35022384-A8E3A842-105C-4660-A4A4-78AFF6090F81

P433

Q35022384-FDDB78A7-33A4-4A17-89D1-48EA0359F632

P478

Q35022384-E93B6AC9-B508-487C-A298-286096AF0307

P577

Q35022384-3743C591-A019-4E8F-B6DC-9AFBFC8DF02D

P5875

Q35022384-F4B98A5E-BC4F-4FD9-B78B-66466EE14CA2

P698

Q35022384-ABCBA8E3-94C2-4E93-A63C-8A07E6BC2279

P932

Q35022384-8E6BE61F-CE91-4727-93BF-34E85DEE8DD3

P3181

P356

PNAS.1030231100

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Prevalence of defective DNA mi ...... series of endometrial cancers.

@en

P2093

Barbara M Buttin

http://www.w3.org/2001/XMLSchema#string

David G Mutch

http://www.w3.org/2001/XMLSchema#string

Elizabeth Swisher

http://www.w3.org/2001/XMLSchema#string

Janet S Rader

http://www.w3.org/2001/XMLSchema#string

Katherine Look

http://www.w3.org/2001/XMLSchema#string

Ken C Walls

http://www.w3.org/2001/XMLSchema#string

Ming-Yu Fan

http://www.w3.org/2001/XMLSchema#string

Paul J Goodfellow

http://www.w3.org/2001/XMLSchema#string

Randall K Gibb

http://www.w3.org/2001/XMLSchema#string

Thomas J Herzog

http://www.w3.org/2001/XMLSchema#string

P2860

Association of hereditary nonpolyposis colorectal cancer-related tumors displaying low microsatellite instability with MSH6 germline mutations.

hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis

Primer3 on the WWW for general users and for biologist programmers

Familial endometrial cancer in female carriers of MSH6 germline mutations

Germ-line msh6 mutations in colorectal cancer families

Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer

A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer

Isolation of an hMSH2-p160 heterodimer that restores DNA mismatch repair to tumor cells

Genotypic and phenotypic progression in endometrial tumorigenesis: determining when defects in DNA mismatch repair and KRAS2 occur.

Atypical HNPCC owing to MSH6 germline mutations: analysis of a large Dutch pedigree

P304

5908-5913

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

7006264

http://www.w3.org/2001/XMLSchema#string

P356

10.1073/PNAS.1030231100

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

100

http://www.w3.org/2001/XMLSchema#string

P577

2003-05-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10772235

http://www.w3.org/2001/XMLSchema#string

P698

12732731

http://www.w3.org/2001/XMLSchema#string

P932

156300

http://www.w3.org/2001/XMLSchema#string